Overall | No complications | Complications | p-value | |
---|---|---|---|---|
n | 29 | 22 | 7 | |
Age (years) | 59 [50, 61] | 56 [50, 60] | 64 [59, 68] | 0.049 |
BMI (kg m−2) | 24.2 [21.8, 27.9] | 24.9 [21.8, 27.7] | 23.3 [22.1, 26.6] | 0.823 |
ASA classification | ||||
1 | 3 (10) | 1 (5) | 2 (29) | 0.221 |
2 | 17 (59) | 14 (64) | 3 (43) | |
3 | 9 (31) | 7 (32) | 2 (29) | |
NYHA classification | ||||
1 | 23 (79) | 18 (82) | 5 (71) | 0.612 |
2 | 6 (21) | 4 (18) | 2 (29) | |
Apfel score (PONV) | ||||
1 | 0 (0) | 0 (0) | 0 (0) | 1.000 |
2 | 3 (10) | 2 (9) | 1 (14) | |
3 | 18 (62) | 14 (64) | 4 (57) | |
4 | 8 (28) | 6 (27) | 2 (29) | |
MET score | 5 [3, 6] | 5 [3, 6] | 5 [3, 6] | 0.917 |
Comorbidities und medication | ||||
Charlson Comorbidity Index | 2 [2, 3] | 3 [2, 6] | 2 [2] | 0.017 |
Arterial hypertension | 8 (28) | 6 (27) | 2 (29) | 1.000 |
Antihypertensive medication | 8 (28) | 6 (27) | 2 (29) | 1.000 |
Other long-term medication | 29 (100) | 22 (100) | 7 (100) | 1.000 |
POSSUM Score | ||||
Morbidity | 53.5 [38.5, 62.5] | 53.4 [33.6, 62.5] | 55.0 [42.8, 66.5] | 0.524 |
Mortality | 2.6 [1.7, 3.9] | 2.6 [1.5, 3.8] | 3.3 [2.0, 4.2] | 0.523 |